| UniProt ID | CTL2_HUMAN | |
|---|---|---|
| UniProt AC | Q8IWA5 | |
| Protein Name | Choline transporter-like protein 2 | |
| Gene Name | SLC44A2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 706 | |
| Subcellular Localization |
Membrane Multi-pass membrane protein. |
|
| Protein Description | Isoform 1, but not isoform 3, exhibits some choline transporter activity.. | |
| Protein Sequence | MGDERPHYYGKHGTPQKYDPTFKGPIYNRGCTDIICCVFLLLAIVGYVAVGIIAWTHGDPRKVIYPTDSRGEFCGQKGTKNENKPYLFYFNIVKCASPLVLLEFQCPTPQICVEKCPDRYLTYLNARSSRDFEYYKQFCVPGFKNNKGVAEVLQDGDCPAVLIPSKPLARRCFPAIHAYKGVLMVGNETTYEDGHGSRKNITDLVEGAKKANGVLEARQLAMRIFEDYTVSWYWIIIGLVIAMAMSLLFIILLRFLAGIMVWVMIIMVILVLGYGIFHCYMEYSRLRGEAGSDVSLVDLGFQTDFRVYLHLRQTWLAFMIILSILEVIIILLLIFLRKRILIAIALIKEASRAVGYVMCSLLYPLVTFFLLCLCIAYWASTAVFLSTSNEAVYKIFDDSPCPFTAKTCNPETFPSSNESRQCPNARCQFAFYGGESGYHRALLGLQIFNAFMFFWLANFVLALGQVTLAGAFASYYWALRKPDDLPAFPLFSAFGRALRYHTGSLAFGALILAIVQIIRVILEYLDQRLKAAENKFAKCLMTCLKCCFWCLEKFIKFLNRNAYIMIAIYGTNFCTSARNAFFLLMRNIIRVAVLDKVTDFLFLLGKLLIVGSVGILAFFFFTHRIRIVQDTAPPLNYYWVPILTVIVGSYLIAHGFFSVYGMCVDTLFLCFLEDLERNDGSAERPYFMSSTLKKLLNKTNKKAAES | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 8 | Phosphorylation | MGDERPHYYGKHGTP CCCCCCCCCCCCCCC | 19.32 | 28152594 | |
| 9 | Phosphorylation | GDERPHYYGKHGTPQ CCCCCCCCCCCCCCC | 19.36 | 28152594 | |
| 10 (in isoform 3) | Phosphorylation | - | 14.33 | 29978859 | |
| 12 (in isoform 3) | Phosphorylation | - | 40.78 | 29978859 | |
| 14 | Phosphorylation | HYYGKHGTPQKYDPT CCCCCCCCCCCCCCC | 23.43 | 25159151 | |
| 16 (in isoform 3) | Phosphorylation | - | 57.70 | 29978859 | |
| 17 (in isoform 1) | Ubiquitination | - | 53.47 | 21906983 | |
| 17 | Ubiquitination | GKHGTPQKYDPTFKG CCCCCCCCCCCCCCC | 53.47 | 21906983 | |
| 18 | Phosphorylation | KHGTPQKYDPTFKGP CCCCCCCCCCCCCCC | 23.16 | 28176443 | |
| 21 | Phosphorylation | TPQKYDPTFKGPIYN CCCCCCCCCCCCCCC | 34.77 | 28152594 | |
| 27 | Phosphorylation | PTFKGPIYNRGCTDI CCCCCCCCCCCHHHH | 11.26 | - | |
| 115 | Acetylation | TPQICVEKCPDRYLT CCCEEHHHCCHHHHH | 30.58 | 7925323 | |
| 120 | Phosphorylation | VEKCPDRYLTYLNAR HHHCCHHHHHHHHCC | 15.69 | - | |
| 165 | Phosphorylation | CPAVLIPSKPLARRC CCEEEECCCHHHHHH | 39.65 | 24719451 | |
| 187 | N-linked_Glycosylation | KGVLMVGNETTYEDG CEEEEECCCCCCCCC | 31.84 | 19349973 | |
| 199 | Ubiquitination | EDGHGSRKNITDLVE CCCCCCCCCHHHHHH | 55.16 | - | |
| 200 | N-linked_Glycosylation | DGHGSRKNITDLVEG CCCCCCCCHHHHHHH | 41.08 | 17660510 | |
| 202 | Phosphorylation | HGSRKNITDLVEGAK CCCCCCHHHHHHHHH | 32.45 | - | |
| 207 (in isoform 2) | Ubiquitination | - | 34.91 | 21906983 | |
| 209 | Ubiquitination | TDLVEGAKKANGVLE HHHHHHHHHCCCHHH | 64.37 | 21906983 | |
| 209 (in isoform 1) | Ubiquitination | - | 64.37 | 21906983 | |
| 303 | Phosphorylation | LVDLGFQTDFRVYLH EEECCCCCCHHHHHH | 34.54 | - | |
| 404 (in isoform 2) | Ubiquitination | - | 16.64 | 21906983 | |
| 406 | Ubiquitination | SPCPFTAKTCNPETF CCCCCCCCCCCCCCC | 51.02 | 21906983 | |
| 406 (in isoform 1) | Ubiquitination | - | 51.02 | 21906983 | |
| 417 | N-linked_Glycosylation | PETFPSSNESRQCPN CCCCCCCCCCCCCCC | 56.45 | 17660510 | |
| 479 (in isoform 2) | Ubiquitination | - | 4.47 | 21906983 | |
| 481 (in isoform 1) | Ubiquitination | - | 54.36 | 21906983 | |
| 481 | Ubiquitination | SYYWALRKPDDLPAF HHHHHHCCCCCCCCC | 54.36 | 21906983 | |
| 492 | Phosphorylation | LPAFPLFSAFGRALR CCCCHHHHHHHHHHH | 30.30 | - | |
| 500 | Phosphorylation | AFGRALRYHTGSLAF HHHHHHHHHHHHHHH | 12.46 | 28270605 | |
| 502 | Phosphorylation | GRALRYHTGSLAFGA HHHHHHHHHHHHHHH | 21.38 | 28270605 | |
| 504 | Phosphorylation | ALRYHTGSLAFGALI HHHHHHHHHHHHHHH | 20.06 | 28270605 | |
| 563 | Phosphorylation | KFLNRNAYIMIAIYG HHHCCCCEEEEEECC | 8.45 | - | |
| 681 | Phosphorylation | DLERNDGSAERPYFM HHHHCCCCCCCCHHH | 29.80 | 28060719 | |
| 686 | Phosphorylation | DGSAERPYFMSSTLK CCCCCCCHHHHHHHH | 20.38 | 28060719 | |
| 689 | Phosphorylation | AERPYFMSSTLKKLL CCCCHHHHHHHHHHH | 15.40 | 20873877 | |
| 690 | Phosphorylation | ERPYFMSSTLKKLLN CCCHHHHHHHHHHHH | 26.43 | 20873877 | |
| 691 | Phosphorylation | RPYFMSSTLKKLLNK CCHHHHHHHHHHHHH | 34.98 | 25849741 | |
| 693 (in isoform 1) | Ubiquitination | - | 41.27 | 21906983 | |
| 693 | Ubiquitination | YFMSSTLKKLLNKTN HHHHHHHHHHHHHHH | 41.27 | 2190698 | |
| 698 | Ubiquitination | TLKKLLNKTNKKAAE HHHHHHHHHHHHHHC | 54.14 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CTL2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CTL2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CTL2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of CTL2_HUMAN !! | ||||
| Kegg Disease | |
|---|---|
| There are no disease associations of PTM sites. | |
| OMIM Disease | |
| There are no disease associations of PTM sites. | |
| Kegg Drug | |
| There are no disease associations of PTM sites. | |
| DrugBank | |
| DB00122 | Choline |
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."; Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.; Nat. Biotechnol. 27:378-386(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-187 AND ASN-200, AND MASSSPECTROMETRY. | |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-187 AND ASN-200, AND MASSSPECTROMETRY. | |